NASDAQ •
Healthcare •
Biotechnology •
Quote as of 05/26/2026 14:33
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1,476.17 mln
Float185 mln
Earnings Date08/06/2026
Piotroski F-Score
3
/ 9
Below average
Relative Strength
99
/ 100
Top performer
Debt / Equity
0.01
Debt-free
ROE
-53.01
Deeply negative
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
SELLAS Life Sciences Group is a New York-based biopharmaceutical company working to bring new cancer treatments to patients. Its two main drug candidates target cancer through different mechanisms ? one by training the immune system to fight tumors, and the other by blocking a protein that helps cancer cells grow. The company works alongside well-known partners, including Merck and Memorial Sloan Kettering Cancer Center, to advance these treatments through clinical trials covering a range of cancer types.
